Blog
Medtech, explained
How medical devices are cleared and approved, how their safety is tracked, how Medicare covers and pays for them, and how medtech companies raise money, with the public data behind each. Written for founders, regulatory and reimbursement teams, clinicians, hospital buyers, students and investors.
Regulatory pathways
510(k) vs De Novo vs PMA: the three FDA pathways for medical devices compared
510(k) vs De Novo vs PMA: how the three FDA device pathways differ in risk class, evidence, review standard and outcome, and how to tell which one applies.
November 19, 2026 · 6 min read
Guides
How to check if a medical device is FDA cleared or approved
Is this device FDA approved? How to do an FDA cleared device lookup in the 510(k), De Novo and PMA databases, and why FDA registered does not mean approved.
November 19, 2026 · 6 min read
Device safety
What is MAUDE? FDA's medical device adverse event database explained
What is the MAUDE database? How FDA's medical device adverse event reports are collected under 21 CFR 803, who must report, and what MAUDE data cannot show.
November 19, 2026 · 6 min read
FDA programs
The FDA Breakthrough Devices Program: criteria, benefits and the full list
Breakthrough device designation explained: FDA Breakthrough Devices Program criteria under section 515B, how to request it, and what it offers.
November 19, 2026 · 6 min read
Reimbursement
How medical device reimbursement works: coding, coverage and payment
Medical device reimbursement explained: how coding, Medicare coverage and payment systems fit together, and what a medtech reimbursement strategy has to cover.
November 19, 2026 · 6 min read
Investing and funding
How investors invest in medtech: stages, investors and exits
How medtech venture capital and other investors fund medical device companies: funding stages, the milestones that drive each round, and how investors exit.
November 19, 2026 · 6 min read
Regulatory pathways
What is a 510(k)? FDA premarket notification and substantial equivalence explained
What is a 510(k)? How FDA premarket notification works, what substantial equivalence and a predicate device mean, and how to look up 510(k) clearances.
November 19, 2026 · 6 min read
Regulatory pathways
The De Novo pathway: how novel low-to-moderate risk devices reach market
De Novo FDA classification explained: when a De Novo request is used instead of a 510(k), what it must show, how review works, and what a grant creates.
November 19, 2026 · 6 min read
Regulatory pathways
What is PMA? FDA premarket approval for Class III devices
PMA FDA premarket approval explained: which devices need it, what the application contains, how review works, and the PMA supplement types after approval.
November 19, 2026 · 6 min read
Regulatory pathways
FDA device classes (I, II, III) and product codes explained
FDA device classification explained: what Class I, II and III mean, how general and special controls work, and how to read an FDA product code.
November 19, 2026 · 6 min read
FDA programs
Investigational Device Exemption (IDE): how medical device clinical trials work
Investigational device exemption (IDE) explained: when a device study needs FDA approval, significant vs non-significant risk, and pivotal trials.
November 19, 2026 · 7 min read
Device safety
How to search MAUDE and read device adverse event reports
MAUDE search guide: how to find MDR reports and device malfunction reports in FDA's database and openFDA, read a report, and avoid common traps.
November 19, 2026 · 7 min read
Device safety
Medical device recalls: Class I, II and III explained, and how to look them up
Medical device recall lookup: what FDA Class I, II and III device recalls mean, how corrections and removals work under 21 CFR 806, and where to search.
November 19, 2026 · 7 min read
Reimbursement
Medicare NCDs vs LCDs: how coverage decisions for devices are made
NCD vs LCD: how Medicare national coverage determinations and local coverage determinations differ, who writes them, and how each process and timeline works.
November 19, 2026 · 6 min read
Reimbursement
NTAP: Medicare's new technology add-on payment for inpatient devices
NTAP explained: new technology add-on payment criteria under 42 CFR 412.87, the 65 percent cap, the Breakthrough device pathway and the application cycle.
November 19, 2026 · 7 min read
Reimbursement
Transitional pass-through payment for devices in hospital outpatient care
Transitional pass-through payment for devices under OPPS: the 42 CFR 419.66 criteria, cost tests, the Breakthrough pathway and how long it lasts.
November 19, 2026 · 7 min read
Reimbursement
TCET: Medicare's Transitional Coverage for Emerging Technologies
TCET Medicare coverage explained: which Breakthrough Devices qualify, the five-per-year limit, the timeline, evidence plans, and the 2026 pause for RAPID.
November 19, 2026 · 6 min read
Investing and funding
How to find a medtech company's funding with SEC Form D
How to use SEC Form D filings to see how much a private medtech company raised: what Form D shows, what it leaves out, and how to search EDGAR for free.
November 19, 2026 · 6 min read
Investing and funding
SBIR and STTR grants for medical device companies
How SBIR medical device grants and STTR awards work: NIH SBIR phases, eligibility, the 2026 reauthorization, and how to look up past awards for free.
November 19, 2026 · 5 min read
Investing and funding
Medtech due diligence with free public data: a checklist
A medtech due diligence checklist using free public data: FDA decisions, clinical trials, MAUDE reports, recalls, Medicare coverage, SEC filings and grants.
November 19, 2026 · 6 min read